[go: up one dir, main page]

ES8606863A1 - Un procedimiento para la preparacion de oxazolidinas - Google Patents

Un procedimiento para la preparacion de oxazolidinas

Info

Publication number
ES8606863A1
ES8606863A1 ES537487A ES537487A ES8606863A1 ES 8606863 A1 ES8606863 A1 ES 8606863A1 ES 537487 A ES537487 A ES 537487A ES 537487 A ES537487 A ES 537487A ES 8606863 A1 ES8606863 A1 ES 8606863A1
Authority
ES
Spain
Prior art keywords
signifies
increased protein
protein breakdown
treating diabetes
oxazolidines
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
ES537487A
Other languages
English (en)
Other versions
ES537487A0 (es
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
F Hoffmann La Roche AG
Original Assignee
F Hoffmann La Roche AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from CH6070/83A external-priority patent/CH655931A5/de
Application filed by F Hoffmann La Roche AG filed Critical F Hoffmann La Roche AG
Publication of ES537487A0 publication Critical patent/ES537487A0/es
Publication of ES8606863A1 publication Critical patent/ES8606863A1/es
Expired legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D263/00—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings
    • C07D263/02—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings
    • C07D263/04—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having no double bonds between ring members or between ring members and non-ring members
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D263/00—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings
    • C07D263/02—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings
    • C07D263/04—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having no double bonds between ring members or between ring members and non-ring members
    • C07D263/06—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having no double bonds between ring members or between ring members and non-ring members with hydrocarbon radicals, substituted by oxygen atoms, attached to ring carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D333/00—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
    • C07D333/02—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings
    • C07D333/04—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom
    • C07D333/26—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D333/38—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
    • C07D409/06—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/06—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)

Abstract

PROCEDIMIENTO PARA LA PREPARACION DE OXAZOLIDINAS. CONSISTE EN HACER REACCIONAR UNA AMINA DE FORMULA (II) CON UN COMPUESTO DE FORMULA TCHO, EN DONDE T ES CARBALCOXILO INFERIOR PARA OBTENER OXAZOLIDINA DE FORMULA (I) O SUS SALES FISIOLOGICAMENTE COMPATIBLES. APLICACION FARMACOLOGICA.
ES537487A 1983-11-10 1984-11-08 Un procedimiento para la preparacion de oxazolidinas Expired ES8606863A1 (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
CH6070/83A CH655931A5 (en) 1983-11-10 1983-11-10 Oxazolidines
CH449984 1984-09-20

Publications (2)

Publication Number Publication Date
ES537487A0 ES537487A0 (es) 1986-05-01
ES8606863A1 true ES8606863A1 (es) 1986-05-01

Family

ID=25695620

Family Applications (1)

Application Number Title Priority Date Filing Date
ES537487A Expired ES8606863A1 (es) 1983-11-10 1984-11-08 Un procedimiento para la preparacion de oxazolidinas

Country Status (22)

Country Link
US (2) US4743604A (es)
AT (1) AT387771B (es)
AU (1) AU576531B2 (es)
BE (1) BE900983A (es)
CA (1) CA1249992A (es)
DE (1) DE3438411A1 (es)
DK (1) DK520584A (es)
ES (1) ES8606863A1 (es)
FI (1) FI844152L (es)
FR (1) FR2554814B1 (es)
GB (1) GB2149405B (es)
HU (1) HU193465B (es)
IL (1) IL73427A (es)
IT (1) IT1177033B (es)
LU (1) LU85631A1 (es)
MC (1) MC1641A1 (es)
NL (1) NL8403308A (es)
NO (1) NO844501L (es)
NZ (1) NZ210105A (es)
PH (1) PH22462A (es)
PT (1) PT79485B (es)
SE (1) SE463099B (es)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HU203330B (en) * 1987-06-10 1991-07-29 Pfizer Process for producing oxazolidin-2-one derivatives and hypoglychemic pharmaceutical compositions containing them
FI892341L (fi) * 1988-06-10 1989-12-11 Hoffmann La Roche Propanolaminderivat.
US5321036A (en) * 1993-02-10 1994-06-14 Bristol-Myers Squibb Company Thiazole and oxazole-based β3 adrenergic receptor agonists
US5563171A (en) * 1993-11-05 1996-10-08 American Cyanamid Company Treatment of glaucoma and ocular hypertension with β3-adrenergic agonists
US5578638A (en) * 1993-11-05 1996-11-26 American Cyanamid Company Treatment of glaucoma and ocular hypertension with β3 -adrenergic agonists
SK111195A3 (en) * 1994-09-13 1997-06-04 Sandoz Technology Ltd Bicyclic ethers substituted with oxazole and thiazole, process for producing thereof and pharmaceutical composition containing same
US7510849B2 (en) * 2004-01-29 2009-03-31 Glucolight Corporation OCT based method for diagnosis and therapy
US7254429B2 (en) 2004-08-11 2007-08-07 Glucolight Corporation Method and apparatus for monitoring glucose levels in a biological tissue
US8036727B2 (en) 2004-08-11 2011-10-11 Glt Acquisition Corp. Methods for noninvasively measuring analyte levels in a subject
AU2006235535A1 (en) 2005-04-13 2006-10-19 Glt Acquisition Corp. Method for data reduction and calibration of an OCT-based blood glucose monitor
US8571617B2 (en) * 2008-03-04 2013-10-29 Glt Acquisition Corp. Flowometry in optical coherence tomography for analyte level estimation
US9784726B2 (en) 2013-01-08 2017-10-10 Atrogi Ab Screening method, a kit, a method of treatment and a compound for use in a method of treatment
GB201714734D0 (en) 2017-09-13 2017-10-25 Atrogi Ab New compounds and uses
GB201714740D0 (en) 2017-09-13 2017-10-25 Atrogi Ab New compounds and uses
GB201714745D0 (en) 2017-09-13 2017-10-25 Atrogi Ab New compounds and uses
GB201714736D0 (en) 2017-09-13 2017-10-25 Atrogi Ab New compounds and uses
GB201903832D0 (en) 2019-03-20 2019-05-01 Atrogi Ab New compounds and methods
GB202205895D0 (en) 2022-04-22 2022-06-08 Atrogi Ab New medical uses

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA979912A (en) * 1970-06-22 1975-12-16 Frederic P. Hauck Tetrahydronaphthyloxyaminopropanols and related compounds
GB1301134A (en) * 1970-07-18 1972-12-29 Pfizer Ltd SUBSTITUTED 1-PHENYL-2-ALLYLAMINO-ALKANOLS, 1-PHENYL-2-ALLYLAMINO-ALKANES AND alpha-AMINOALKYLPHENYL KETONES

Also Published As

Publication number Publication date
ES537487A0 (es) 1986-05-01
SE8405632L (sv) 1985-05-11
GB2149405B (en) 1987-07-01
IT8423307A0 (it) 1984-10-25
FI844152A7 (fi) 1985-05-11
IT8423307A1 (it) 1986-04-25
IL73427A (en) 1988-02-29
AU576531B2 (en) 1988-09-01
NO844501L (no) 1985-05-13
ATA355384A (de) 1988-08-15
FI844152A0 (fi) 1984-10-22
US4743604A (en) 1988-05-10
MC1641A1 (fr) 1986-01-09
CA1249992A (en) 1989-02-14
DK520584A (da) 1985-05-11
FR2554814B1 (fr) 1988-03-11
NL8403308A (nl) 1985-06-03
LU85631A1 (fr) 1986-06-04
HUT36103A (en) 1985-08-28
SE8405632D0 (sv) 1984-11-09
IL73427A0 (en) 1985-02-28
IT1177033B (it) 1987-08-26
NZ210105A (en) 1988-10-28
PT79485A (en) 1984-12-01
HU193465B (en) 1987-10-28
AT387771B (de) 1989-03-10
AU3527584A (en) 1985-05-16
SE463099B (sv) 1990-10-08
FR2554814A1 (fr) 1985-05-17
GB2149405A (en) 1985-06-12
BE900983A (fr) 1985-05-06
DK520584D0 (da) 1984-11-01
DE3438411A1 (de) 1985-05-30
US4871755A (en) 1989-10-03
FI844152L (fi) 1985-05-11
GB8428335D0 (en) 1984-12-19
PT79485B (en) 1987-01-13
PH22462A (en) 1988-09-12

Similar Documents

Publication Publication Date Title
ES8606863A1 (es) Un procedimiento para la preparacion de oxazolidinas
PH25295A (en) Pyridine ethanolamine derivatives
AU8508682A (en) 1-aryl-2-aminomethyl cyclopropane carboxylates
ZA857523B (en) Pharmaceutical compositions containing diazepines and having a paf-antagonistic activity
EP0134400A3 (en) Substituted pyridylmethylthio-(or sulfinyl-)benzimidazoles having a secretolytic activity
KR930007919A (ko) 니트로스아민을 함유하지 않는, 질산염 - 안정화된 3-이소티아졸론 화합물의 제조방법
KR970704438A (ko) 티아졸 및 티아디아졸 화합물의 D 도파민 수용체 리간드로서의 용도(Use of Thiazole and Thiadiazole Compounds as D Dopamine Receptor Ligands)
ATE175195T1 (de) Naphthamide, verfahren zur herstellung und ihre therapeutische anwendung
JPS57150349A (en) New feedstuff additives
ES8301460A1 (es) Un procedimiento para la preparacion de l-amino acidos n-sustituidos.
ATE2044T1 (de) 6h-1,2,4,6-thiatriazin-1,1-dioxide, herbizide, die diese verbindungen enthalten, ihre anwendung als herbizide und verfahren zu ihrer herstellung.
YU118389A (en) Derivatives of proponol amine and process for obtaining thereof
DE3460841D1 (en) Mercaptoacetic acid and 3-mercaptopropionic acid amide derivatives for use in treatment of a human or animal body, some new derivatives and pharmaceutical compositions containing them
ZA838990B (en) Substituted benzylcycloalkenylurea derivatives
ES8406460A1 (es) Procedimiento para preparar nuevos derivados de etendiamina y guanidina
ES470195A1 (es) Procedimiento para la preparacion de anilidas de acido ci- clopropancarboxilico
JPS56100765A (en) Pyridine derivative
JPS57200397A (en) Novel aldohexopyranose-, aldopentopyranose-, or and medicament composition comprising it aldopentofuranose- nitrosourea compound, its preparation
KR900004343A (ko) 간질 치료용 피라졸로피리딘
JPS5283850A (en) Heterocyclic compounds
ES435778A1 (es) Un metodo para preparar una 2,6-dinitroanilina.
JPS56158747A (en) Polypeptide
GB1293909A (en) Halopyridine derivatives
ES429204A1 (es) Procedimiento para la obtencion de n-(2-(n'-ciclohexil-n' -metil - n'metilen)-4,6-dibromo-fenil)-3-etoxi-4 - valeriano-xi - benzamida, hidrocloruro.
JPS5785819A (en) Production of polycarbonate